C World Wide Group Holding A Insmed Inc Transaction History

C World Wide Group Holding A

  • $8.2 Billion
  • Q4 2024

A detailed history of C World Wide Group Holding A transactions in Insmed Inc stock. As of the latest transaction made, C World Wide Group Holding A holds 343,110 shares of INSM stock, worth $26.9 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
343,110
Previous 343,110 -0.0%
Holding current value
$26.9 Million
Previous $25 Million 5.43%
% of portfolio
0.29%
Previous 0.26%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 04, 2021
SELL
$32.28 - $44.3 $1.29 Million - $1.77 Million
-40,000 Reduced 10.44%
343,110 $11.7 Million
Q4 2020

Feb 05, 2021
SELL
$31.45 - $40.54 $1.89 Million - $2.43 Million
-60,000 Reduced 13.54%
383,110 $12.8 Million
Q3 2019

Nov 04, 2019
BUY
$15.49 - $25.78 $774,500 - $1.29 Million
50,000 Added 12.72%
443,110 $7.82 Million
Q2 2019

Aug 02, 2019
BUY
$23.0 - $32.19 $6.44 Million - $9.01 Million
280,000 Added 247.55%
393,110 $10.1 Million
Q4 2018

Feb 12, 2019
SELL
$11.6 - $18.7 $1.48 Million - $2.38 Million
-127,532 Reduced 53.0%
113,110 $1.48 Million
Q3 2018

Nov 05, 2018
SELL
$18.95 - $28.08 $3.23 Million - $4.78 Million
-170,312 Reduced 41.44%
240,642 $4.87 Million
Q2 2018

Aug 03, 2018
BUY
$20.0 - $29.72 $765,840 - $1.14 Million
38,292 Added 10.28%
410,954 $9.72 Million
Q1 2018

May 03, 2018
SELL
$21.69 - $32.99 $419,593 - $638,191
-19,345 Reduced 4.93%
372,662 $8.39 Million
Q4 2017

Feb 07, 2018
SELL
$26.43 - $31.78 $1.46 Million - $1.76 Million
-55,422 Reduced 12.39%
392,007 $12.2 Million
Q3 2017

Nov 06, 2017
BUY
$11.61 - $31.21 $5.19 Million - $14 Million
447,429
447,429 $14 Million

Others Institutions Holding INSM

# of Institutions
497
Shares Held
189M
Call Options Held
3.21M
Put Options Held
2.72M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10.6B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track C World Wide Group Holding A Portfolio

Follow C World Wide Group Holding A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

News

Stay updated on C World Wide Group Holding A with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email